U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
[ ] Form 10-K [ ] Form 20F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR
For Period Ended: June 30, 2002
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: ________________
Nothing in this form shall be construed to imply that
the Commission has verified any information contained
herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates: Not Applicable
_______________________________________________________________________________
PART I - REGISTRANT INFORMATION
Full Name of Registrant: NOCOPI TECHNOLOGIES, INC.
Address of Principal 537 Apple Street
Executive Office: West Conshohocken, PA 19428
PART II - RULES 12B-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the Registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
[x] (a) The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort or expense;
[ ] (b) (i) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20F, 11-K or Form N-SAR, or portion thereof will be
filed on or before the fifteenth calendar day following the prescribed due date;
or
[x] (ii) The subject quarterly report or transition report on Form
10-Q, or portion thereof will be filed on or before the fifth calendar day
following the prescribed due date.
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III - NARRATIVE
An individual customarily responsible for assisting in the preparation of
Registrant's periodic reports (including Form 10-QSB) was injured during July
and only recently (during the second week of August, 2002) has recovered
sufficiently to return to work on a part-time basis and participate in the
preparation of Registrant's Form 10-QSB for the quarter ended June 30, 2002. In
view of the recent adverse publicity concerning a number of Issuers whose
reports pursuant to the Securities Exchange Act of 1934 contained errors, and
the recent passage of the Sarbanes-Oxley Act of 2002, Registrant has determined
that it is desirable for the subject filing to be minimally delayed in order for
such individual to participate fully in its preparation.
PART IV - OTHER INFORMATION
(1) Name and address of person to contact in regard to this notification:
Thomas F. Hurley, Esq.
Luke E. Dembosky, Esq.
Hangley Aronchick Segal & Pudlin
One Logan Square - 27th Floor
Philadelphia, PA 19103
Telephone: (215) 496-7052
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
Registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [X] No
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
NOCOPI TECHNOLOGIES, INC.
--------------------------
(Name of Registrant)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: August 14, 2002 By: /s/ Rudolph A. Lutterschmidt
--------------- ---------------------------------
Rudolph A. Lutterschmidt,
Chief Financial Officer
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.